Total raised
$20K
Last: Seed 2018-03
Stage
Seed
Founded
2017
Headcount
4
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
Dermafence has developed a proprietary technology for the treatment of burns. The company's technology is based on a GRAS formulation with a novel mechanism of action designed to bar energy from progressing to the deeper layers of the skin.
Dermafence has developed a first aid burn formulation that restores and protects epidermal "skin barrier" function following exposure to insults that introduce energy to the skin.
Funding history · 1 round · $20K total
2018-03
Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Dermafence founded?
- Dermafence was founded in May 2017.
- What is Dermafence's primary focus?
- Dermafence's primary focus is on developing proprietary technology for the treatment of burns, specifically a first aid burn formulation.
- Where is Dermafence headquartered?
- Dermafence is headquartered in Jerusalem, Israel.
- Has Dermafence received any grants?
- Yes, Dermafence received a grant of $10,000 from the IIA in January 2017 and another $10,000 from the IIA in March 2018.
- When did Dermafence complete its Seed funding round?
- Dermafence completed a Seed funding round in March 2018, with MassChallenge Israel as a lead investor.
- What is Dermafence's current employee count?
- Dermafence currently has 4 employees.
- What is the total amount of funding Dermafence has raised?
- Dermafence has raised a total of $20,000 USD, primarily from grants. For full financing history, refer to startupim.
- Which markets does Dermafence target geographically?
- Dermafence targets the United States and Israel as its geographic markets.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2CB2B2C
Highlights
1 Patents
Tags
burnsmedical-technologiespatientsmedical-productsdoctorsfirst-aid